Literature DB >> 17346783

Thromboembolic complications in beta-thalassemia: Beyond the horizon.

Inusha Panigrahi1, Sarita Agarwal.   

Abstract

Patients with beta-thalassemia have a chronic hypercoagulable state with increased incidence of thromboembolic episodes. The thrombotic complications are more common in thalassemia intermedia than in regularly transfused thalassemia major. The pathophysiologic defects include inherent red cell defects, platelet abnormalities, deficiency of coagulation inhibitors, and additional acquired abnormalities like cardiac and liver dysfunction, hormonal deficiencies. These factors and possible preventive measures are discussed in this review. An illustrative case is also presented.

Entities:  

Mesh:

Year:  2007        PMID: 17346783     DOI: 10.1016/j.thromres.2007.01.015

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  7 in total

Review 1.  Hypercoagulability in congenital haemolytic anaemias.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Blood Transfus       Date:  2012-10-25       Impact factor: 3.443

2.  Laboratory tests for coagulation system monitoring in a patient with β-thalassemia.

Authors:  Elena A Seregina; Olga F Nikulina; Nina V Tsvetaeva; Maya N Rodionova; Irina V Gribkova; Elena B Orel; Anastasiya P Zapariy; Anatoliy V Erasov; Anna N Balandina; Natalya M Ananyeva; Fazoil I Ataullakhanov
Journal:  Int J Hematol       Date:  2014-03-09       Impact factor: 2.490

3.  Prevalence of thrombotic risk factors among beta-thalassemia patients from Western Iran.

Authors:  Zohreh Rahimi; Mandana Ghaderi; Ronald L Nagel; Adriana Muniz
Journal:  J Thromb Thrombolysis       Date:  2007-11-04       Impact factor: 2.300

4.  Vascular endothelial growth factor in children with thalassemia major.

Authors:  Sameh S Fahmey; Hassan F Naguib; Sanna S Abdelshafy; Rasha E Alashry
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-06-05       Impact factor: 2.576

5.  Vascular endothelial dysfunction in β-thalassemia occurs despite increased eNOS expression and preserved vascular smooth muscle cell reactivity to NO.

Authors:  Ekatherina Stoyanova; Marie Trudel; Hady Felfly; Wafaa Lemsaddek; Damien Garcia; Guy Cloutier
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

6.  Relationship between Serum Visfatin and Vascular Inflammation Markers Level in Beta Thalassemia Major Patients.

Authors:  Elham Hashemi Dehkordi; Seyed Mohammad Kazem Nourbakhsh; Noushin Rostampour; Fateme Alizadeh Boroujeni
Journal:  Int J Prev Med       Date:  2014-10

7.  Transcranial Doppler Ultrasonography in Beta-thalassemia Major Patients Without and With Thrombocytosis.

Authors:  Abdolhamid Shariat; Masoume Nazeri; Amin Abolhasani Foroughi; Mehran Karimi
Journal:  Iran Red Crescent Med J       Date:  2013-03-05       Impact factor: 0.611

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.